RRBP1 and familial dilated cardiomyopathy: Furthermore, RRBP1 was significantly increased in the DCM and ICM groups compared with levels in the CNT group (311±208 vs. 100±54 AU, p<0.001, and 203±75 vs. 100±54 AU, p<0.01, respectively) (Fig. 3A) as well as kinectin (140±76 vs. 100±25 AU, p<0.05, and 161±94 vs. 100±25 AU, p<0.05, respectively) (Fig. 3C), Nogo A (128±33 vs. 100±13 AU, p<0.01, and 149±38 vs. 100±13 AU, p<0.001, respectively) (Fig. 4A), and Nogo B (177±76 vs. 100±52 AU, p<0.01, and 234±125 vs. 100±52 AU, p<0.001, respectively) (Fig. 4B).